Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
156.9 USD | -0.73% |
|
+33.52% | +62.72% |
26/06 | Monetary policy is getting even more confusing | ![]() |
26/06 | Citigroup Downgrades Sarepta Therapeutics to Neutral From Buy, Raises Price Target to $176 From $172 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+62.72% | 14.83B | |
+16.49% | 122B | |
+21.73% | 115B | |
+22.59% | 26.64B | |
-21.81% | 19.91B | |
-16.59% | 16.32B | |
-18.81% | 15.49B | |
-44.74% | 15.52B | |
+3.09% | 13.67B | |
+122.59% | 11.12B |
- Stock Market
- Equities
- SRPT Stock
- News Sarepta Therapeutics, Inc.
- Sarepta Therapeutics Insider Bought Shares Worth $2,001,800, According to a Recent SEC Filing